Les Tari, PhD

Senior Vice President
Cidara Therapeutics
San Diego, California, United States

Disclosure information not submitted.

Presentation(s):

• 227 - A Randomized, Placebo-controlled Trial to Evaluate the Safety and Efficacy of CD388, a Novel Drug-Fc-Conjugate, for Prevention of Illness due to Influenza A and B in Healthy Unvaccinated Participants

  Monday, October 20, 2025
  3:51 PM - 4:03 PM US ET